<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li C</submitter><funding>Natural Science Foundation of Beijing Municipality</funding><funding>Ministry of Science and Technology of the People’s Republic of China</funding><funding>National Natural Science Foundation of China</funding><pagination>286</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7969628</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(4)</volume><pubmed_abstract>p97/VCP, an evolutionarily concerned ATPase, partakes in multiple cellular proteostatic processes, including the endoplasmic reticulum (ER)-associated protein degradation (ERAD). Elevated expression of p97 is common in many cancers and is often associated with poor survival. Here we report that the levels of p97 positively correlated with the histological grade, tumor size, and lymph node metastasis in breast cancers. We further examined p97 expression in the stem-like cancer cells or cancer stem cells (CSCs), a cell population that purportedly underscores cancer initiation, therapeutic resistance, and recurrence. We found that p97 was consistently at a higher level in the CD44&lt;sup>+&lt;/sup>/CD24&lt;sup>-&lt;/sup>, ALDH&lt;sup>+&lt;/sup>, or PKH26&lt;sup>+&lt;/sup> CSC populations than the respective non-CSC </pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>p97/VCP is highly expressed in the stem-like cells of breast cancer and controls cancer stemness partly through the unfolded protein response.</pubmed_title><pmcid>PMC7969628</pmcid><funding_grant_id>16G10825</funding_grant_id><funding_grant_id>81550019</funding_grant_id><funding_grant_id>2016YFC1302203</funding_grant_id><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>Zheng Z</pubmed_authors><pubmed_authors>Xie F</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Dong Y</pubmed_authors><pubmed_authors>Ji J</pubmed_authors><pubmed_authors>Nie M</pubmed_authors><pubmed_authors>Fan Q</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Quan H</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>p97/VCP is highly expressed in the stem-like cells of breast cancer and controls cancer stemness partly through the unfolded protein response.</name><description>p97/VCP, an evolutionarily concerned ATPase, partakes in multiple cellular proteostatic processes, including the endoplasmic reticulum (ER)-associated protein degradation (ERAD). Elevated expression of p97 is common in many cancers and is often associated with poor survival. Here we report that the levels of p97 positively correlated with the histological grade, tumor size, and lymph node metastasis in breast cancers. We further examined p97 expression in the stem-like cancer cells or cancer stem cells (CSCs), a cell population that purportedly underscores cancer initiation, therapeutic resistance, and recurrence. We found that p97 was consistently at a higher level in the CD44&lt;sup>+&lt;/sup>/CD24&lt;sup>-&lt;/sup>, ALDH&lt;sup>+&lt;/sup>, or PKH26&lt;sup>+&lt;/sup> CSC populations than the respective non-CSC </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-19T15:37:48.886Z</modification><creation>2022-02-09T10:50:23.858Z</creation></dates><accession>S-EPMC7969628</accession><cross_references><pubmed>33731668</pubmed><doi>10.1038/s41419-021-03555-5</doi></cross_references></HashMap>